Hepion Pharmaceuticals, Inc.
HEPA
$0.3181
$0.02066.92%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -72.85% | -29.22% | -83.86% | -11.36% | -23.33% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -15.76% | -57.44% | 44.84% | -13.96% | 36.09% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -54.29% | -35.61% | -64.47% | -11.76% | -17.78% |
|
|||||
Total Current Assets | -54.29% | -35.61% | -64.47% | -11.76% | -17.78% |
Net Property, Plant & Equipment | -100.00% | -21.50% | -17.20% | -24.92% | -14.53% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -82.36% | 0.00% | 3.51% | 40.02% |
Total Assets | -56.56% | -38.19% | -62.41% | -11.63% | -27.63% |
|
|||||
Total Accounts Payable | 18.20% | -58.28% | -70.18% | -36.26% | -21.87% |
Total Accrued Expenses | -92.25% | -18.40% | -52.76% | -54.36% | -40.18% |
Short-term Debt | 37.71% | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -23.43% | 15.00% | 15.62% | 3.21% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -86.28% | 188.52% |
Total Other Current Liabilities | -- | -- | -- | -86.28% | 188.52% |
Total Current Liabilities | 15.75% | 178.39% | -62.10% | -51.34% | -17.37% |
|
|||||
Total Current Liabilities | 15.75% | 178.39% | -62.10% | -51.34% | -17.37% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 37.71% | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -55.75% | -28.00% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -76.30% | -4.54% | -74.84% | 7.78% | 134.82% |
Total Liabilities | -15.64% | 68.35% | -71.09% | -21.69% | 22.26% |
|
|||||
Common Stock & APIC | 0.01% | 0.38% | 0.01% | 1.31% | 0.95% |
Retained Earnings | -0.65% | -2.10% | -1.73% | -1.27% | -5.18% |
Treasury Stock & Other | 115.43% | 0.00% | -684.78% | 111.68% | 16.08% |
Total Common Equity | -69.31% | -212.59% | -67.96% | 4.31% | -61.38% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | -69.31% | -212.59% | -67.96% | 4.31% | -61.38% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -358.15% | -111.42% | -52.64% | 3.30% | -54.94% |
|